Ngaba Izindandatho Zengxowankulu Zinikezela Ukukhulelwa Nokunciphisa Umngcipheko we-STD?

Xa amaqanda asebhinqa aqala ukuqaliswa njengezixhobo zokukhusela, iimpendulo zahlanganiswa. Ngakolunye uhlangothi, beyindlela entsha yokufumana abantu ukusebenzisa i-hormonal contraception. Amanqanaba e-hormone yegazi aya kuba ngaphantsi kunye nokuhanjiswa kwendawo. Bekulungele kwaye kulula ukuyisebenzisa. Ngakolunye uhlangothi, abanye abantu babengenakunqweneleka ukuba bafake. Babenenkxalabo malunga noko kwakuza kwenzeka ngexesha lesini.

Babecinga ukuba bangabanqatha okanye bangakhululeki.

Ngokuhamba kwexesha, abantu baye bajwayele ukujonga ingcamango yesondo. Abanye abantu bayabathanda. Abanye abantu abanomdla kakhulu. Kuyacaca ke, ukuba kulula ukuyisebenzisa kubantu abazimisele ukuwasebenzisa. Ngaphezu koko, yindlela efanelekileyo yokuhambisa iamolekyuli ezincinci kumfazi.

Ingcongolo yeVaginal kunye ne-STD Prevention

Ukukhulelwa kwe-hormonal akuyona indlela kuphela yindandatho zamabhinqa ezinokusetyenziswa. Kwiminyaka yakutshanje, izazinzulu kunye nabaphandi baye bahlola ezinye iindlela ezisetyenziswayo kwezi zixhobo. Enye into efana nokuhambisa iziyobisi kunye namayeza. Ngokomzekelo, izilingo ezininzi zibonise ukuba amaconti angama-vaginal ayenokuba yindlela ephumelelayo yokuhambisa ukuhlaselwa kwangaphambili kwe- HIV.

I-pre-exposure prophylaxis yinto efana ngayo. Abantu banikezelwa ngamachiza phambi kokuba bavelele kwi-HIV. Injongo kukunciphisa umngcipheko wokusuleleka kwintsholongwane.

Ngokuqhelekileyo, izifundo ezininzi eziphambi kwe-prophylaxis (okanye i-PrEP) zenziwa kwintlekeleko yabasetyhini kunye nabasetyhini abangaxhatshaliyo .

Isizukulwana sokuqala sophando lwe-PrEP siphumelele kakhulu. Kubonise ukuba ukuthatha izidakamizwa ze-antiretroviral kunokunciphisa umngcipheko womntu we-HIV. Nangona kunjalo, oko kusebenza kuphela xa abantu bethabatha iziyobisi rhoqo .

Ngelishwa, akuyena wonke umntu owayengqinelanayo. Ngoko ke, uphando luboniswe ukufumana iindlela zokuthatha ezi zonyango lula. Enye indlela enjalo yayiwahambisa ngeendandatho zangasese.

Ukusebenzisa indandatho yesisindo se-PrEP kufana nokusebenzisa enye yokukhulelwa. Ibhinqa lifaka i-polymer ring kwi-vaginal yayo kwaye ikhupha loo mayeza ngokuzenzekelayo. Isangqa sitshintshwe rhoqo.

Uphando olusisiphakamisayo lubonisa ukuba isangqa esinamayeza e-antiretroviral sinokunciphisa ingozi ye-HIV. Nangona kunjalo, kwizifundo zabantu eziye zabikwa kwangoku, iindandatho azizange ziphephe umngcipheko. Kungenzeka ukuba iifom yexesha elizayo linokusebenza ngempumelelo, njengoko kuboniswe kwizifundo kwiimpawu zeemonkey. Ukudibanisa okuhlukeneyo okanye iiklasi zamachiza zingase zisebenze kangcono ... okanye zibi.

Akukho isondo lesisu esinegayeza le-HIV kwiimarike,. Sekunjalo, enye inokukhululwa kwikamva elibonakalayo. Okubaluleke ngakumbi kukuba oogqirha kunye nososayensi baxoxa malunga nokwenza iindandatho zombini. Kuya kuba yinto echanekileyo ukwenza isistim esinezo zakhiwo zombini kunye nezakhiwo ezichasene ne-HIV. Oku kungabonisa ukutshintsha kolwandle ekuthintekeni.

Nangona kunjalo, kubalulekile ukuba uqaphele ukuba loo mveliso iya kukhusela kuphela kwi-HIV kwaye ayikho enye i- STD . Akuyi kuba ngumlingo wemilingo. Kusengenza umehluko omkhulu kubomi besetyhini abaninzi.

Imithombo:

Baeten, JM, et al. kunye ne-MTN-020 I-ASPIRE Team Study. Ukusetyenziswa kweNgxowa yamaVaginal equkethe iDapivirine ye-HIV-1 Ukuthintela kwabasetyhini. I-New England Journal of Medicine. Ngo-2016 ngoFebruwari 22. Ipapashwe kwi-Intanethi phambi kwePrinta. i-doi: 10.1056 / NEJMoa1506110

Iziko zeSizwe zoLwaphulo-mthetho kunye nezifo ezithintekayo. Ingcongolo yamaVaginal inikeza ukhuselo olukhethekileyo kwi-HIV kwiCandelo elikhulu leMatriki. 2016 NgoFebruwari 22. Kufumaneka 2/22/16 kwi-http: //www.niaid.nih.gov/news/newsreleases/2016/Pages/ASPIRE.aspx

USmith JM, uRustogi R, Teller RS, uSrinivasan P, PM PM Mesquita, uNagaraja U, McNicholl JM, Hendry RM, Dinh CT, uMartin A, uHerold BC, uKiser PF. Ingqungquthela yokunciphisa i-tenofovir disoproxil fumarate ikhusela ngokupheleleyo ii-macaque kwiimingeni ezininzi ze-vaginal-HIV. Proc Natl Acad Sci US A. I-2013 Oktobha 1; 110 (40): 16145-50. i-doi: 10.1073 / pnas.1311355110.